CA Patent

CA3003746A1 — Treatments of accumulated fat with deoxycholic acid and salts thereof

Assigned to Allergan Sales LLC · Expires 2017-05-11 · 9y expired

What this patent protects

Provided herein are methods of treating a variety of disorders related to fat accumulation in humans with pharmaceutical formulations containing deoxycholic acid.

USPTO Abstract

Provided herein are methods of treating a variety of disorders related to fat accumulation in humans with pharmaceutical formulations containing deoxycholic acid.

Drugs covered by this patent

bendamustine-hydrochloride (BENDAMUSTINE HYDROCHLORIDE)

Patent Metadata

Patent number: CA3003746A1
Jurisdiction: CA
Classification: —
Expires: 2017-05-11
Drug substance claim: No
Drug product claim: No
Assignee: Allergan Sales LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.